Rheumatology Network

Treating post-menopausal osteoporosis patients with romosozumab could improve their long-term bone density, a study shows.

Using the fracture assessment tool with older, community-dwelling women can help reduce their risk of hip fracture over time, study shows.

Using biomarkers to assess drug efficacy could pave the way for improved osteoporosis treatment, according to a new study.